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 1 
ABSTRACT 29 
Malnutrition can adversely affect physical and psychological function, influencing both 30 
morbidity and mortality. Despite the prevalence of malnutrition and its associated health and 31 
economic costs, malnutrition remains under-detected and under-treated in differing 32 
healthcare settings. For a subgroup of malnourished individuals, a gastrostomy (a feeding 33 
tube placed directly into the stomach) may be required to provide long-term nutritional 34 
support. In this review we explore the spectrum and consequences of malnutrition in differing 35 
healthcare settings. We then specifically review gastrostomies as a method of providing 36 
nutritional support. The review highlights the origins of gastrostomies, and discusses how 37 
endoscopic and radiological advances have culminated in an increased demand and 38 
placement of gastrostomy feeding tubes. Several studies have raised concerns about the 39 
benefits derived following this intervention and also about the patients selected to undergo 40 
this procedure. These studies are discussed in detail in this review, alongside suggestions for 41 
future research to help better delineate those who will benefit most from this intervention, 42 
and improve understanding about how gastrostomies influence nutritional outcomes.  43 
 44 
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Malnutrition describes a state in which a deficiency, excess or imbalance of energy, protein 48 
and other nutrients causes measurable adverse effects on tissue/body form (body shape, size 49 
and composition), function or clinical outcome.(1) It is a recognised global public health 50 
problem affecting both industrialised and emerging countries.(2) Currently, the State of Food 51 
Insecurity (SOFI) estimates that around 795 million people in the world (just over one in nine 52 
people) are malnourished.(3) Poverty, social isolation and substance misuse contribute 53 
significantly to the burden in developed countries, however the mainstay of  problems are 54 
derived from disease related malnutrition, through reduced dietary intake, increased 55 
metabolic demands and impaired absorption or loss of nutrients.(4)  The consequences of 56 
malnutrition can be profound, leading to deleterious effects on both physical and 57 
psychological function. This can adversely impact clinical outcomes such as morbidity, 58 
mortality, hospital length of stay, hospital readmissions and healthcare costs.(5; 6) Despite the 59 
prevalence of malnutrition and its associated health and economic costs, malnutrition remains 60 
under-detected and under-treated in healthcare settings.(7) 61 
 62 
Prevalence of Malnutrition in Healthcare Settings 63 
In 1994 a landmark paper published by McWhirter et al in the British Medical Journal raised 64 
concerns that 40% (200/500) of patients admitted to an acute UK hospital were 65 
malnourished.(8) A further concern highlighted in this study was that patients continued to 66 
lose weight during their hospital stay (mean weight loss of 5.4%). Since the publication of 67 
this seminal paper, there have been numerous other studies performed in the UK, 68 
demonstrating a prevalence of malnutrition in UK hospitals ranging between 11-45%.(9) 69 
Although considerable heterogeneity exists between these published studies, findings 70 
collectively suggest that malnutrition in hospitals remains highly prevalent in the UK today. 71 
These findings are supported by a recent publication from the British Association for 72 
Parenteral and Enteral Nutrition (BAPEN) using the Malnutrition Universal Screening Tool 73 
µ0867¶ discussed later).(10) This report estimates adult malnutrition to affect: 30% on 74 
admission to hospitals,  34% in hospital wards, 35% admitted to care homes, 35 % already 75 
resident in care homes, 18% admitted to mental health units, > 15% attending hospital 76 
outpatient clinics and 10% of patients visiting general practitioners.(10)  77 
 78 
Problems with malnutrition in healthcare settings are not confined to the United Kingdom 79 
(UK). In a multicentre study evaluating 21,007 patients from 325 hospitals across Europe and 80 
Israel, 27% of patients were subjectively identified as being at nutritional risk.(11) In Latin 81 
 3 
America, a recent systematic review of 66 studies encompassing 29,474 patients from 12 82 
countries, demonstrated a prevalence of disease-related malnutrition on hospital admission 83 
between 40 -60%. Similar findings have been reported from other industrialised nations 84 
across the globe.(12; 13; 14; 15)  85 
 86 
Improving nutritional care through screening and assessment 87 
Over recent decades several publications from differing professional bodies and patient 88 
organisations have raised concerns about the detection of malnutrition.(16; 17; 18; 19) 89 
Consequently, an array of screening and assessment tools have been devised to help assess 90 
malnutrition and determine malnutrition risk. Nutritional screening refers to a rapid and 91 
simple means of predicting malnutrition risk, whereas nutritional assessments determine 92 
whether malnutrition is actually present.(20) The benefits of screening tools are that they can 93 
be used by an array of trained healthcare professionals, whereas nutritional assessments 94 
require greater expertise, and are most frequently performed by trained dietitians.  95 
 96 
The Malnutrition Universal Screening Tool (MUST) is the nutrition screening tool most 97 
frequently used in the UK, incorporating current body mass index, unintentional weight loss 98 
and the presence of any acute disease effect that could compromise nutritional intake for >5 99 
days.(21) It has been shown to have high predictive validity in both the  community and 100 
hospital environments (length of hospital stay, mortality in elderly wards, discharge 101 
destination in orthopaedic patients).(21; 22; 23) Another screening tool adopted is the Nutritional 102 
Risk Screening 2002 (NRS-2002), which includes four questions about: BMI (if it is <20.5), 103 
presence of weight loss in the past three months, presence of low dietary intake in the past 104 
week and the severity of disease.(24) This NRS-2002 was advocated in the 2002 ESPEN 105 
guidelines, however its performance against MUST was recently found to be inferior in the 106 
context of the latest ESPEN consensus definition for malnutrition.(23; 25)  107 
 108 
Other tools used in clinical practice include the Mini Nutrition Assessment (MNA), the 109 
Subjective Global Assessment (SGA) and the Short Nutrition Assessment Questionnaire 110 
(SNAQ).(26; 27; 28) Despite the benefits of nutritional screening in healthcare settings and the 111 
requirement to do so in certain countries (eg. UK, USA), the use of these tools remains highly 112 
variable, with no one tool being universally adopted in all settings.(29; 30)    113 
 114 
 115 
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Economic Costs of Malnutrition  116 
Although the physical and psychological manifestations of malnutrition have been 117 
extensively investigated, until recently there has been limited work evaluating the economic 118 
costs of malnutrition. This paucity of work highlights the difficulties in attributing monetary 119 
value to certain consequences of malnutrition that may be influenced by disease status, 120 
socioeconomic status, life expectancy, alongside the perspective from which the economic 121 
analysis is being undertaken (eg. patient, healthcare professional or general public).(31)  In 122 
European countries the annual costs of disease related malnutrition have been calculated in 123 
The Netherlands (2011), Germany (2006), UK (2012) and Ireland (2007) equating to EUR 124 
1.9 billion, EUR 9 billion, EUR 19.6 billion and EUR 1.5 billion respectively.(32; 33) As a cost 125 
per adult (>18 years) capita for these 4 individual nations, costs translate to EUR 135, EUR 126 
134, EUR 370, EUR 500 respectively. These variations in outcomes highlight the differences 127 
in methodology used to calculate costs, with the UK data considering all healthcare costs eg. 128 
total GP visits and costs for providing domiciliary and home care, compared to the findings 129 
from the Netherlands that only assesses additional costs due to disease related 130 
malnutrition.(32) Improving the understanding of direct healthcare costs of malnutrition (eg. 131 
cost of travelling expenses to patients and carers to receive nutrition support), and of the 132 
indirect healthcare costs such as reduction in work productivity, would help enhance costing 133 
calculations.  134 
 135 
The benefits of health economics data in this field can be demonstrated when considering the 136 
effectiveness and efficacy of interventions for treating malnutrition. This has recently been 137 
the subject of a Cochrane systematic review, supporting the use of nutritional therapy in 138 
reducing healthcare costs. This work also highlights the need for future work to investigate 139 
the impact nutritional therapies have on malnutrition and on hospital readmission rates.(34)  140 
 141 
Nutrition Support 142 
Nutrition support involves the provision of nutrition beyond that provided by normal food 143 
intake using oral supplementation, enteral tube feeding(ETF) and parenteral nutrition 144 
(PN).(19) The goals of nutrition support are to ensure attainPHQWRIDQLQGLYLGXDO¶VQXWULWLRQDO145 
requirements.  Oral nutrition using special diets and supplements is usually considered the 146 
first line therapy in managing malnutrition, however certain individuals may require enteral 147 
or parenteral nutrition when oral intake is reduced or when swallowing is unsafe.(35)  Of these 148 
modalities, enteral nutrition is usually preferred in the context of a normally functioning 149 
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gastrointestinal tract as it is physiological, cheaper and may help maintain gut barrier 150 
function.(36; 37) 151 
 152 
Most patients requiring nutrition support therapy have treatment for less than one month.(38) 153 
When short-term enteral feeding is considered, nasogastric and orogastric tubes are most 154 
frequently used, reflecting their ease of insertion and removal (Figure 1). Tubes range in 155 
length and diameter and can be inserted either at the bedside, at endoscopy or using 156 
radiological guidance. When nutritional intake is likely to be inadequate for more than 4-6 157 
weeks then enteral feeding using a gastrostomy is most frequently considered (Figure 2).(39) 158 
This intervention for providing nutritional support is discussed in further detail below.  159 
 160 
History of Gastrostomies and Techniques of Insertion 161 
A gastrostomy describes a feeding tube placed directly into the stomach via a small incision 162 
through the abdominal wall (Figure 2). It can provide long term enteral nutrition to patients 163 
who have functionally normal gastrointestinal tracts but who cannot meet their nutritional 164 
requirements due to an inadequate oral intake.(39) Infrequently, they may also be used for 165 
decompressing the stomach or proximal small bowel following outflow obstruction or 166 
volvulus.  167 
 168 
The concept of a gastrostomy was first proposed by Egeberg, a Norwegian army surgeon in 169 
1837, however it was only in 1876 when Verneuil used a silver wire to oppose visceral and 170 
parietal surfaces that success was achieved in inserting a surgical gastrostomy.(40) Post-171 
procedural peritonitis was the most frequent limitation to previous attempts at surgical 172 
insertion, with death ensuing in individuals who developed this complication. Stamm 173 
PRGLILHG9HUQHXLO¶V VXUJLFDO WHFKQLTXH LQSULRU WRPRGLILFDWLRQVEHLQJGHYHORSHGE\174 
Dragstedt, Janeway and Witze in the 20th century.(41)  175 
 176 
In 1979, Michael Gauderer and Jeffrey Ponsky revolutionised gastrostomy practice by 177 
pioneering an endoscopic method of insertion in Clevleand, Ohio.(42) The two paediatricians 178 
performed the very first percutaneous endoscopic gastrostomy (PEG) in a 6-month old child, 179 
using a 16 French DePezzar (mushroom tipped) catheter, which they replicated again in a 180 
further 5 paediatric cases.(43) Ponsky then utilised this technique in a cohort of adult patients 181 
with dysphagic strokes, which heightened interest in this novel endoscopic technique.(43)  The 182 
µSXOOWHFKQLTXH¶WKDWWKH\SLRQHHUHGLVFXUUHQWO\RQHRIWKUHHHQGRVFRSLFPHWKRGVIUHTXHQWO\183 
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used today in clinical practice. When compared to previously used surgical methods, 184 
endoscopic insertion was favourable, as it was minimally invasive and incurred lower 185 
morbidity and mortality.  186 
 187 
Two years later in 1981, Preshaw in Canada used fluoroscopic guidance to insert the first 188 
percutaneous radiological gastrostomy (PRG).(44) Like endoscopic methods, modifications of 189 
the original radiological technique have occurred since the original method was conceived. 190 
However, despite these advances endoscopic techniques remain the most popular methods of 191 
insertion internationally, with PRG insertion most frequently reserved for high-risk patients, 192 
oropharyngeal malignancy and when endoscopic passage is technically difficult.(45; 46) 193 
 194 
Indications for Gastrostomy 195 
Since the introduction of endoscopic and radiological insertion techniques for gastrostomy, 196 
there has been increasing demand for this intervention, for an increasing number of clinical 197 
indications. A broad list of indications for which patients are currently being referred for 198 
gastrostomy is given in Table 1. Despite being widely performed the evidence base to support 199 
gastrostomy feeding in certain patient groups is lacking. This is reflected in the National 200 
Confidential Enquiry into Patient Outcome and Death (NCEPOD) report, which reviewed 201 
mortality outcomes post-percutaneous endoscopic gastrostomy insertion between April 2002 202 
and March 2003, identifying a 30-day mortality rate in a cohort of 16,648 patients of 6%.(47) 203 
Subgroup analysis alarmingly showed that 43% died within one week of undergoing PEG 204 
insertion, of whom in 19% the intervention was felt to have been futile. Interestingly, the 205 
NCEPOD data identified a high prevalence of acute chest infections (40%) in those 206 
undergoing PEG placement, which could have influenced these mortality outcomes. The 207 
current evidence regarding gastrostomy feeding in certain patient subgroups is discussed 208 
below.  209 
 210 
Gastrostomy feeding and Dementia 211 
Patients with dementia frequently develop feeding problems, leading to weight loss and 212 
nutritional deficiencies. Up to 85% of these problems develop prior to death suggesting that 213 
difficulties with feeding are an end-stage problem, associated with advanced disease.(48) 214 
Whether or not to use gastrostomies to feed patients with dementia is an emotive and 215 
controversial issue. This controversy is further compounded by the fact that in the late stages 216 
of the illness, individuals lack capacity to express their wishes. The 2010 British Artificial 217 
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Nutrition Survey (BANS) gives insights into the frequency of insertion for dementia, 218 
highlighting that registration of home enteral tube feeding (mainly by gastrostomy) for this 219 
indication declined from 7% in 2004 to 3% (48/1560).(49) This decline reflects concerns 220 
raised in the medical literature about inserting gastrostomies for this indication. 221 
 222 
There is currently a limited number of prospective studies examining outcomes in dementia, 223 
that could help inform clinical practice.(50; 51) In a retrospective cohort study of 361 patients, 224 
mortality was found to be significantly higher in dementia patients compared to any other 225 
patient group (54% 30-day mortality and 90% at 1 year).(52) Our group has recently replicated 226 
this finding in a prospectively followed cohort (n=1023), however the number of insertions 227 
performed for dementia was low (n=5).(53) These concerns have been highlighted in a 228 
Cochrane systematic review, which showed no improvements in survival, quality of life, 229 
nutritional status, function, behaviour or in psychiatric symptoms in patients with advanced 230 
dementia receiving  enteral tube feeding.(54)  231 
 232 
Gastrostomy Feeding in Stroke Patients 233 
Dysphagia is common in patients after a stroke ranging between 23-50%.(55) Whilst 234 
neurological recovery does occur in some patients leading to improvements in swallowing 235 
function, many remain at high risk of developing aspiration pneumonia and malnutrition. 236 
Enteral nutrition is widely advocated in these individuals, however controversy exists as to 237 
the optimal mode of delivery. Two small randomised, studies evaluating PEG versus 238 
nasogastric feeding demonstrated improved mortality outcomes, hospital length of stay and 239 
nutritional indices in patients who had a PEG, suggesting derived benefit.(56; 57)   240 
 241 
However, since these studies were published the FOOD trial, a multicentre study evaluating 242 
enteral nutrition in stroke patients has questioned the potential merits of PEG feeding.(58) 243 
Consisting of three pragmatic randomised controlled trials, the FOOD trial aimed to 244 
determine whether routine oral nutritional supplementation of a normal hospital diet 245 
improved outcomes after stroke (Trial 1); whether early tube feeding improved the outcomes 246 
of dysphagic stroke patients (Trial 2); and whether tube feeding via a PEG resulted in better 247 
outcomes than nasogastric feeding (Trial 3). Results showed no benefit of oral supplements; 248 
however, survival improved when tube feeding was commenced early but at the cost of 249 
poorer functional outcomes. In Trial 3 the best outcome was achieved in the group fed by 250 
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nasogastric tube. These findings have led to reviewing current practice and questioned the 251 
optimal timing of gastrostomy feeding in these patients. 252 
 253 
Gastrostomy Feeding in Oropharyngeal Malignancy 254 
Patients with oropharyngeal malignancy are at risk of malnutrition due to direct effects from 255 
the tumour (e.g. reduced appetite, host response, problems ingesting food due to tumour size) 256 
and also from the anticancer therapies themselves (e.g. radiation induced mucositis). 257 
Gastrostomies are widely performed in this patient group as a prophylactic measure (prior to 258 
radiotherapy and chemotherapy), but also when swallowing problems occur directly because 259 
of the malignancy itself. Despite the potential merits of enteral feeding in this patient group, 260 
there has only been one randomised controlled trial evaluating gastrostomy feeding in 261 
comparison to other enteral feeding methods.(59) This has led to a recent Cochrane review 262 
concluding that there is insufficient evidence to determine the optimal method of enteral 263 
feeding in patients with head and neck cancer receiving radiotherapy and/or 264 
chemoradiotherapy.(60)  265 
 266 
Gastrostomy Feeding in Chronic Neurodegenerative Conditions 267 
Gastrostomies are increasingly being used in the treatment of patients with neurogenic 268 
dysphagia.(61) Whilst the exact aetiology of the neurogenic dysphagia is frequently unknown, 269 
it is commonly encountered in patients with Motor Neurone disease (Amyotrophic Lateral 270 
6FOHURVLV+XQWLQJWRQ¶VFKRUHD0XOWLSOHVFOHURVLVDQGLQSDWLHQWVZLWK3DUNLQVRQ¶VGLVHDVH271 
When bulbar weakness develops leading to dyarthria and dysphagia, gastrostomies are 272 
frequently considered to aid nutrition, reduce choking episodes and to minimise the risk of 273 
aspiration pneumonia.  274 
 275 
There are currently no randomised controlled trials evaluating outcomes of patients with 276 
chronic neurodegenerative conditions following gastrostomy insertion. Of the observational 277 
studies that have been performed, findings are frequently conflicting, retrospective and 278 
predominantly from motor neurone disease cohorts.(62; 63; 64) Based on the limited available 279 
literature, the most recent Cochrane review tentatively concludes that gastrostomy feeding 280 
may confer a survival and nutritional advantage in those with motor neurone disease (MND), 281 
however further work is required with regards to evaluating quality of life.(65) The recent 282 
ProGas study has provided further insights into this area since the Cochrane review, 283 
evaluating methods of gastrostomy insertion and optimal timing.(66)     284 
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 286 
Gastrostomy Feeding in other Patient Sub-groups 287 
Gastrostomy insertion is performed for a number of other indications (highlighted in Table 288 
1), however evidence to support its use in these differing sub-groups is questionable. An 289 
example of this is in patients who suffer head injuries following road traffic accidents, falls, 290 
violence or sport who are often considered for gastrostomy whilst on Intensive Care Units. 291 
Currently, the latest Cochrane review of nutritional support in head injury patients (analysis 292 
of 11 trials) suggests early feeding may improve survival and disability, however this benefit 293 
may be best derived from total parenteral nutrition rather than enteral nutrition methods.(67) 294 
When comparing nasogastric feeding with gastrostomy feeding in this patient group, 295 
gastrostomy feeding may reduce pneumonia rates but does not derive any mortality 296 
benefit.(68)  297 
 298 
Another group of patients seen in adult services with gastrostomies are patients with cerebral 299 
palsy. Gastrostomy insertion is increasingly being performed in children with this condition 300 
with the aim of improving weight, nutritional indices and quality of life.(69; 70; 71) These 301 
individuals are then moved into adult services as they reach adulthood. Unfortunately, like in 302 
many other areas of gastrostomy feeing there is a paucity of well-designed randomised 303 
controlled trials evaluating gastrostomy feeding in this patient group, leading to uncertainty 304 
regarding the merits of this intervention.(72) This uncertainty is reflected in other conditions 305 
(anorexia nervosa, achalasia, frailty, burns patients) and highlights the need for well-306 
conducted studies, to help better inform clinical practice.  307 
 308 
 309 
Gastrostomy Feeding and Nutritional Outcomes 310 
Feeding via a Gastrostomy 311 
Enteral feeds can be delivered via gastrostomies using continuous, bolus or intermittent 312 
infusion methods.(73) These feeds are nutritionally complete (containing protein or amino 313 
acids, carbohydrate, fat, water, minerals and vitamins) and are available in fibre free and fibre 314 
enriched forms. Determining the type of feed used is influenced by DQLQGLYLGXDO¶Vnutritional 315 
requirements, gastrointestinal absorption, motility and also by their co-morbidities, such as 316 
renal or liver disease.(74) Continuous infusion provides patients with feed over 24 hours and is 317 
most frequently reserved for very ill patients.(75) This regimen is associated with an increased 318 
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risk of drug nutrient interactions and may also increase intragastric pH leading to bacterial 319 
overgrowth.(35) Bolus feeding describes the delivery of 200-400 mL of feed (administered 320 
either by push or gravity methods over 15- 60 minutes) periodically throughout the day, 321 
permitting medications to be given at times different to feeds. This can lead to abdominal 322 
EORDWLQJGLDUUKRHDDQGV\PSWRPVDQDORJRXVWRWKRVHVHHQLQWKHµGXPSLQJV\QGURPH¶ZKHUH323 
rapid gastric emptying occurs. Intermittent infusions provide feeds over a longer duration 324 
than bolus feeding using an infusion pump, thereby minimising the adverse symptoms but 325 
also permitting breaks for the patients unlike continuous feeding.  326 
 327 
Impact on nutritional outcomes.  328 
The nutritional benefits derived from gastrostomy feeding are not clearly established. The 329 
uncertainties that exist reflect the heterogeneity in populations previously assessed, the 330 
paucity of data examining long-term nutritional outcomes and confounders such as timing of 331 
gastrostomy feeding that may have influenced reported outcomes. In addition, the assessment 332 
of nutritional status is highly variable. In stroke patients, a frequently cited historical paper 333 
showed that gastrostomy feeding was better than nasogastric feeding at improving weight 334 
gain and anthropometric measurements at 6 weeks.(56) This landmark study has helped inform 335 
future clinical practice, however it is to be recognised that results were derived from only 30 336 
patients from 2 UK centres. The more recent and significantly larger, multicentre FOOD trial 337 
has enhanced understanding about the timing and method of enteral feeding in stroke 338 
patients, however uncertainty still remains about how gastrostomies impact nutritional status 339 
in these individuals.(76)  340 
 341 
The ProGas study provides insights into how gastrostomy feeding influences nutritional 342 
outcomes in motor neurone disease.(66) This study was not a randomised controlled trial, 343 
however its importance to clinical practice has been widely recognised, by being the first 344 
multicenter, longitudinal cohort study in this field. In this study the authors report outcomes 345 
of 170 patients who had valid weight measurements 3 months post gastrostomy insertion. 346 
Findings showed that in 84 (49%) patients, weight loss was more than 1kg compared to 347 
baseline values. These findings suggest nutritional gains may be limited in this group of 348 
patients, however determine the timing of gastrostomy insertion may by critical to achieving 349 
maximal gains in the future. The uncertainties highlighted here emphasize the need for better 350 
studies looking at nutritional outcomes in gastrostomy patients. This would also help improve 351 
understanding of the efficacy of this intervention in reducing malnutrition. 352 
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 354 
 355 
Optimising referral for Gastrostomy insertion and aftercare 356 
There has been increasing interest in improving patient selection for gastrostomy insertion.(77; 357 
78; 79)
 One method used internationally to optimise referral practice is to employ institutional 358 
guidelines that use a standardised referral protocol. Use of a multidisciplinary team in 359 
assessment of patients and dissemination of evidence can allow both carers and healthcare 360 
professionals make an informed decision. This approach has been shown (in observational 361 
studies) to improve the selection of patients referred for gastrostomy.(80; 81; 82) 362 
 363 
When considering whether insertion of a gastrostomy tube is appropriate, the question that 364 
PXVWEHDVNHGLVZKHWKHUJDVWURVWRP\IHHGLQJZRXOGPDLQWDLQRULPSURYHDSDWLHQW¶VTXDOLW\365 
of life. This question must be answered in the context of the underlying diagnosis and 366 
SURJQRVLV FRQVLGHULQJ PRUDO DQG HWKLFDO LVVXHV DV ZHOO DV UHVSHFWLQJ WKH SDWLHQW¶V ZLVKHV367 
Guidelines exist to aid clinicians in making decisions on gastrostomy feeding, however the 368 
decision to insert a feeding tube should always be made on an individual basis.(19; 83) 369 
 370 
Another factor that may be influencing outcomes following gastrostomy insertion is 371 
variations in the organisation of aftercare services. In a UK study looking at provision of 372 
services for gastrostomy, only 64% of units had a dedicated aftercare service.(84) The benefits 373 
of dedicated home enteral feed teams have been shown to reduce costs and morbidity 374 
associated with gastrostomy feeding.(85; 86) Given that most complications of gastrostomy 375 
feeding occur following hospital discharge, effort should be made to improve the delivery of 376 
aftercare and procurement of these services for the benefit of patients. 377 
 378 
Ethical and Legal Considerations of Gastrostomy feeding 379 
Gastrostomy feeding raises ethical and legal issues. Both the Royal College of Physicians and 380 
the General Medical Council in the UK have provided guidance on oral feeding and 381 
nutrition.(87; 88) Artificial Feeding is considered a medical treatment in legal terms and 382 
requires valid consent prior to commencement. For consent to be valid the person giving 383 
consent must have the capacity to do so voluntarily after being given sufficient information to 384 
guide informed choice.  When a patient has capacity their wish to consent to or refuse 385 
treatment should be upheld, even if that decision may lead to death.  When a patient lacks 386 
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capacity an independent mental capacity advocate should represent that individual. The 387 
multidisciplinary team caring for the patient is responsible for giving, withholding or 388 
withdrawing treatment, including artificial feeding and hydration and should consider any 389 
DGYDQFH GLUHFWLYHV WKH SDWLHQW¶V SURJQRVLV DQG WKH OLkely benefits of gastrostomy feeding 390 
when making decisions. A limited trial of feeding may sometimes be used but strict criteria 391 
regarding what constitutes success should be determined prior to starting gastrostomy 392 
feeding.(74) Conflicts sometimes arise between health care professionals or between the 393 
professionals and those close to the patient. In such circumstances it may be necessary to 394 
seek legal advice or seek resolution through a local clinical ethics committee.(89) Anecdotally, 395 
such conflicts appear to be rising with increased patient and family demands for intervention, 396 
which may in turn be influenced by emotion or by cultural beliefs. 397 
 398 
The NICE dementia guidelines highlight the importance of quality of life in advanced 399 
dementia and support the role of palliative care in these individuals from diagnosis until 400 
death. Best practice in these patients could be to encourage eating and drinking by mouth for 401 
as long as tolerated, utilising good feeding techniques, altering food consistencies and to 402 
promote good mouth care. Assisting hand feeding in this way has recently been shown to be 403 
of benefit in elderly patients, with volunteer assistance improving oral intake and enjoyment 404 
of meals.(90) When disease progression is such that the patient no longer wants to eat or drink, 405 
then rather than inserting a gastrostomy tube, end of life care pathways might be considered. 406 
Views held by carers and medical staff may prevent progression to end of life care pathways. 407 
A questionnaire survey demonstrated that allied health care professionals were more likely 408 
than physicians to consider gastrostomy feeding when presented with patient scenarios 409 
relating to malnutrition.(91)  410 
 411 
Conclusion 412 
Malnutrition is a global public health concern. These problems are not restricted to emerging 413 
countries, but also highly prevalent in healthcare systems in developed countries. Despite 414 
advances in nutritional care, evidence from across the globe suggests that detection of 415 
malnutrition remains sup-optimal. Currently, billions are being spent on the consequences of 416 
malnutrition, when VLPSOH FRUUHFWLRQV RI SDWLHQW¶V QXWULWLRQDO VWDWXVHV DSSHDU WR EH417 
overlooked or not considered as a sufficient medical problem. To help ease this burden to 418 
patients and healthcare systems, detection and appropriate treatment need to be significantly 419 
improved, alongside improvements in the evidence base for selected treatments. This has 420 
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particular relevance to gastrostomy feeding where the benefits for malnourished individuals 421 
and their caregivers remains uncertain. Future gastrostomy research should aim to better 422 
delineate those who will benefit most from this intervention; determine the optimal timing of 423 
this procedure and enhance understating on how gastrostomies can improve nutritional 424 
outcomes in malnourished individuals.     425 
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Table 1 ±Conditions where Gastrostomy feeding is considered 670 
Neurological Indications Obstruction 
Cerebrovascular Disease Oropharyngeal Cancer 
Motor Neurone Disease Oesophageal Cancer 
Multiple Sclerosis Oesophageal Stricture 
Muscular Dystrophy   
Parkinson's Disease Miscellaneous 
Cerebral Palsy Burns patients 
Dementia Fistulae 
  Cystic Fibrosis 
Reduced Conscious Level/Cognition Short Bowel Syndromes (eg. Crohn¶s disease) 
Head Injury Mental health (Anorexia/ Learning Difficulties) 
Intensive Care Patients   
 671 
672 
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Figure 1: Methods of Enteral feeding 673 
 674 
 675 
 23 
Figure 2:  A gastrostomy feeding tube  676 
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